Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2024.03.015 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Tim Wittig und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Department of Internal Medicine, Neurology and Dermatology, University Hospital Leipzig, Leipzig, Germany; Helmholtz Institute…. Hauptthemen laut MEDLINE: Cardiovascular Agents, Coated Materials, Biocompatible, Drug-Eluting Stents, Femoral Artery. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit.
Abstract (Originalsprache)
BACKGROUND: Limited comparative data exist on different interventional strategies for endovascular revascularization of complex femoropopliteal interventions. OBJECTIVES: In this study, the authors aimed to compare a stent-avoiding (SA) vs a stent-preferred (SP) strategy, promoting optimal lesion preparation and the use of drug-eluting technologies in both arms. METHODS: Within a prospective, multicenter, pilot study, 120 patients with symptomatic complex femoropopliteal lesions (Rutherford classification 2-4, mean lesion length 187.7 ± 78.3 mm, 79.2% total occlusions) were randomly assigned in a 1:1 fashion to endovascular treatment with either paclitaxel-coated balloons or polymer-coated, paclitaxel-eluting stents. Lesion preparation including the use of devices for plaque modification and/or removal was at the operators' discretion in both treatment arms. RESULTS: In the SA group, lesion preparation was more frequently performed (71.7% SA [43/60] vs 51.7% [31/60] SP; P = 0.038) with a high provisional stenting rate (48.3% [29/60]). At the 12-month follow-up, primary patency was 78.2% (43/55) in the SA group and 78.6% (44/56) in the SP group (P = 1.0; relative risk: 0.995; 95% CI: 0.818-1.210). Freedom from major adverse events was determined in 93.1% (54/58) in the SA group and in 94.9% (56/59) in the SP group (P = 0.717; relative risk: 0.981; 95% CI: 0.895-1.075), with all adverse events attributable to clinically driven target lesion revascularization. CONCLUSIONS: Both endovascular strategies promoting lesion preparation before the use of drug-eluting devices suggest promising efficacy and safety results in complex femoropopliteal procedures with a high proportion of total occlusions through 12 months. Ongoing follow-up will show whether different results emerge over time. (Best Endovascular Strategy for Complex Lesions of the Superficial Femoral Artery [BEST-SFA]; NCT03776799).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Angiology, Department of Internal Medicine, Neurology and Dermatology, University Hospital Leipzig, Leipzig, Germany; Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Center…
- Division of Angiology, Department of Internal Medicine, Neurology and Dermatology, University Hospital Leipzig, Leipzig, Germany.
- Department of Internal Medicine, Elblandklinikum Radebeul, Radebeul, Germany.
- Department of Angiology, Regiomed Gefäßzentrum Sonneberg, Sonneberg, Germany.
- Department of Angiology, Kreiskrankenhaus Torgau, Torgau, Germany.
Förderung
- Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit
Zitieren
APA
Wittig, T., Schmidt, A., Fuß, T., Thieme, M., Maiwald, L., Düsing, S., Konert, M., Fischer, A., Scheinert, D., & Steiner, S. (2024). Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.03.015
Vancouver
Wittig T, Schmidt A, Fuß T, Thieme M, Maiwald L, Düsing S, et al. Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.03.015
BibTeX
@article{Wittig2024,
author = {Wittig, Tim and Schmidt, Andrej and Fuß, Torsten and Thieme, Marcus and Maiwald, Lars and Düsing, Sandra and Konert, Manuela and Fischer, Axel and Scheinert, Dierk and Steiner, Sabine},
title = {Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2024.03.015}
}
EUVIMED